SMSobia Masood

Sobia Masood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sobia Masood has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Limited Predictive Value of TIMI Score for In-Hospital Mortality in NSTEMI: Cardiogenic Shock as a Stronger Independent Predictor

    by Sobia Masood, Mariam Anwar, Syed Ashad Shoaeb Ahmed, Asra Ayaz Siddiqui, Junaid Ali

    Objectives: This study aimed to evaluate the reliability and predictive strength of the Thrombolysis in Myocardial Infarction (TIMI) risk score for in-hospital mortality among patients with Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) admitted to Pakistan's largest tertiary care cardiac center. Methodology: This retrospective cohort study was conducted at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Data were extracted from a prospectively maintained hospital-based registry. Records of patients who underwent percutaneous coronary intervention (PCI) following admission for NSTEMI between September 2022 and August 2023 were reviewed. Results: A total of 717 NSTEMI patients were included, of whom 77.7% were male, with a mean age of 55 ± 10.2 years and an average body mass index (BMI) of 27.7. Common comorbidities included hypertension (61.6%) and diabetes mellitus (31.5%). Electrocardiographic findings showed ST-segment deviation ≥0.5 mm in 45% of cases. In-hospital mortality was observed in 2% of the cohort. The TIMI score demonstrated poor predictive performance for in-hospital mortality (AUC = 0.751, P = 0.001). Multivariate analysis identified cardiogenic shock as an independent predictor of in-hospital mortality (OR 102.96, P < 0.001). Conclusion: The findings suggest that the TIMI risk score lacks a significant association with in-hospital mortality in NSTEMI patients. Conversely, cardiogenic shock emerged as a strong independent predictor of in-hospital mortality. These results highlight the need to re-evaluate risk stratification tools in this population.

  • Open Access

    THE PREDICTIVE UTILITY OF GRACE SCORE FOR OBSTRUCTIVE CORONARY ARTERY DISEASE IN PATIENTS WITH NON ST ELEVATION MYOCARDIAL INFARCTION

    by Haroon Ishaq, Bilal Akhtar, Mukesh Kumar, Ghulam Shabbir Shar, Abdul Hakeem, Sobia Masood, Tahir Saghir, Musa Karim

    Objectives: The objective of this study was to determine the predictive value of GRACE score for predicting obstructive coronary artery disease in patients with non ST-segment elevation myocardial infarction (NSTEMI). Methodology: This cross-sectional study was conducted at the largest public sector cardiac care center of the Pakistan between January 2020 and June 2020. In this study, we included adult patients diagnosed with NSTEMI and correlation of GRACE score was assessed with angiographic finding of obstructive CAD defined as ≥50% stenosis in the left main or ≥70% stenosis in other coronary arteries. Results: A total of 227 patients were included in this study, out of whom 72.2% (164) were male patients and mean age was 55.77 ± 9.15 years. Mean GRACE score was found to be 95.89 ± 21.15. On coronary angiography obstructive CAD was present in 84.6% (192) of the patients. Area under the cure for predicting obstructive CAD was 0.669 [0.552 to 0.785]. The optimal cutoff value of GRACE score was ≥ 84 with sensitivity of 79.7% [73.3% to 85.1%] and specificity of 57.1% [39.3% to 73.7%]. GRACE score of ≥ 84 was found to be an independent predictor of obstructive CAD with odds ratio of 4.33 [1.61 - 11.64; p=0.004] adjusted for gender, age, hypertension, diabetes, family history of CAD, and smoking. Conclusion: GRACE score has a moderate predictive value in predicting obstructive CAD in patients with NSTEMI. The optimal cutoff value of 84 is an independent predictor with good sensitivity but moderate specificity in predicting obstructive CAD.


  • Angiographic profile and outcomes of Pakistani women with ST elevation myocardial infarction

    by Sobia Masood, Kanwal Fatima Aamir, Khalid Naseeb, Quratulain Shaikh, Tahir Saghir, Syed Nadeem Qamar

    Objective: To evaluate the angiographic profile and outcome of primary percutaneous coronary intervention in female patients with acute myocardial infarction. Method: The cross-sectional study was conducted at the National Institute of Cardiovascular Diseases, Karachi, from July 1, 2017, to March 31, 2018, and comprised female patients presenting with acute myocardial infarction who underwent primary percutaneous coronary intervention and got enrolled in the National Cardiovascular Data Registry. Follow-up calls were made 1 year post-intervention and outcomes were noted. Data was analysed using SPSS 21. Results: Of the 522 female patients with a mean age of 57.41±11.14 years, 334(64%) were hypertensive, 202(38.7%) diabetic, 16(3.1%) had a family history of coronary artery disease, and 9(1.7%) were smokers. Single-vessel disease was observed in 183(35.1%) patients, and three-vessel disease in 144(27.6%). Post-procedure thrombolysis in myocardial infarction flow (0-II) was observed in 29(5.6%) patients, bleeding in 2(0.4%), and in-hospital mortality was in 22(4.2%). Telephonic follow-up was successfully conducted in 436(87.5%) of the discharged patients, and, of them 15(3.4%) had expired and recurrence was reported by 10(2.3%) patients and 8(80%) of them underwent re-intervention. Conclusion: More than half the female patients had multi-vessel disease and bifurcation lesion was observed in more than three-fourth of the sample. Key Words: Coronary artery disease, Women, Percutaneous coronary intervention, Acute myocardial infarction, Angiography, Pakistan. Continuous...

  • Open Access

    Acute ST-Elevation Myocardial Infarction Before and During the COVID-19 Pandemic: What is the Clinically Significant Difference?

    by Naeem Mengal, Tahir Saghir, Syed N. Hassan Rizvi, Naveedullah Khan, Nadeem Qamar, Sobia Masood, Abida Badini

    In the current coronavirus disease-2019 (COVID-19) pandemic, the pattern of hospital admissions for acute ST-elevation myocardial infarction (STEMI) is changing, and increased mortality and morbidity is being noted in these patients. Cardiac manifestations of COVID-19 are complex and include STEMI, myocarditis, myocardial injury, and cardiomyopathy. The objective of our study was to compare the data of patients with STEMI presenting in COVID-19 versus the non-COVID-19 era. We analyzed the clinical and angiographic characteristics of STEMI patients undergoing primary percutaneous coronary intervention (PCI) at our center. The primary outcome variables were admission rate for STEMI, mean total ischemic time (TIT), coronary artery disease burden, mean ejection fraction, and in-hospital mortality for three defined groups. Group A consisted of patients who underwent primary PCI from March through April 2020. Group B included patients who underwent primary PCI from January to February 2020. Group C consisted of patients who underwent primary PCI from March to April 2019. We then compared the data among the three groups and calculated any significant p-value (p<.001). In Group A, 1139 patients were admitted for primary PCI. The mean admission rate was 18.6 ± 4.36 admissions per day. There were 1535 patients in Group B and an admission rate of 26.01 ± 4.90 (p<.001 compared to Group A). In Group C, there were 1537 patients and an admission rate of 24.8 ± 4.55 (p<.001, compared to Group A). The mean TIT was 429.25±272.16 minutes for Group A, 359.78±148.04 minutes for Group B, and 346.75±207.31 minutes for Group C (p<.001). A higher mortality rate was noted in Group A (COVID-19 era) versus Group C (non-COVID-19 era; p<.001). A lower admission rate, higher TIT, and higher mortality rates were noted in patients with acute STEMI during the COVID-19 pandemic compared to the pre-COVID era. During the COVID-19 pandemic, physicians should bear in mind that patients with STEMI have increased mortality and morbidity. Where possible, efforts should be made for timely management of these critical patients to decrease mortality.